1
|
A fragment-based drug discovery strategy applied to the identification of NDM-1 β-lactamase inhibitors. Eur J Med Chem 2022; 240:114599. [PMID: 35841882 DOI: 10.1016/j.ejmech.2022.114599] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2022] [Revised: 06/26/2022] [Accepted: 07/07/2022] [Indexed: 11/23/2022]
Abstract
Hydrolysis of β-lactam drugs, a major class of antibiotics, by serine or metallo-β-lactamases (SBL or MBL) is one of the main mechanisms for antibiotic resistance. New Delhi Metallo-β-lactamase-1 (NDM-1), an acquired metallo-carbapenemase first reported in 2009, is currently considered one of the most clinically relevant targets for the development of β-lactam-β-lactamase inhibitor combinations active on NDM-producing clinical isolates. Identification of scaffolds that could be further rationally pharmacomodulated to design new and efficient NDM-1 inhibitors is thus urgently needed. Fragment-based drug discovery (FBDD) has become of great interest for the development of new drugs for the past few years and combination of several FBDD strategies, such as virtual and NMR screening, can reduce the drawbacks of each of them independently. Our methodology starting from a high throughput virtual screening on NDM-1 of a large library (more than 700,000 compounds) allowed, after slicing the hit molecules into fragments, to build a targeted library. These hit fragments were included in an in-house untargeted library fragments that was screened by Saturation Transfer Difference (STD) Nuclear Magnetic Resonance (NMR). 37 fragments were finally identified and used to establish a pharmacophore. 10 molecules based on these hit fragments were synthesized to validate our strategy. Indenone 89 that combined two identified fragments shows an inhibitory activity on NDM-1 with a Ki value of 4 μM.
Collapse
|
5
|
Blackburn C, Barrett C, Chin J, Garcia K, Gigstad K, Gould A, Gutierrez J, Harrison S, Hoar K, Lynch C, Rowland RS, Tsu C, Ringeling J, Xu H. Potent Histone Deacetylase Inhibitors Derived from 4-(Aminomethyl)-N-hydroxybenzamide with High Selectivity for the HDAC6 Isoform. J Med Chem 2013; 56:7201-11. [DOI: 10.1021/jm400385r] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Christopher Blackburn
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Cynthia Barrett
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Janice Chin
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Kris Garcia
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Kenneth Gigstad
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Alexandra Gould
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Juan Gutierrez
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Sean Harrison
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Kara Hoar
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Chrissie Lynch
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - R. Scott Rowland
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - Chris Tsu
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - John Ringeling
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| | - He Xu
- Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne
Street, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
6
|
Pessoa-Mahana H, Recabarren-Gajardo G, Temer JF, Zapata-Torres G, Pessoa-Mahana CD, Barría CS, Araya-Maturana R. Synthesis, docking studies and biological evaluation of benzo[b]thiophen-2-yl-3-(4-arylpiperazin-1-yl)-propan-1-one derivatives on 5-HT1A serotonin receptors. Molecules 2012; 17:1388-407. [PMID: 22306829 PMCID: PMC6268179 DOI: 10.3390/molecules17021388] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2011] [Revised: 01/28/2012] [Accepted: 01/30/2012] [Indexed: 01/03/2023] Open
Abstract
A series of novel benzo[b]thiophen-2-yl-3-(4-arylpiperazin-1-yl)-propan-1-one derivatives 6a-f, 7a-f and their corresponding alcohols 8a-f were synthesized and evaluated for their affinity towards 5-HT(1A) receptors. The influence of arylpiperazine moiety and benzo[b]thiophene ring substitutions on binding affinity was studied. The most promising analogue, 1-(benzo[b]thiophen-2-yl)-3-(4-(pyridin-2-yl)piperazin-1-yl)propan-1-one (7e) displayed micromolar affinity (K(i) = 2.30 μM) toward 5-HT(1A) sites. Docking studies shed light on the relevant electrostatic interactions which could explain the observed affinity for this compound.
Collapse
Affiliation(s)
- Hernán Pessoa-Mahana
- Departamento de Química Orgánica y Fisicoquímica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Casilla 233, Santiago 1, Chile.
| | | | | | | | | | | | | |
Collapse
|
8
|
Dinica R, Furdui B, Cârâc G, Stanciu C. Fluorescent N-Heterocycles via One-Pot Tandem Reactions. CHEMISTRY JOURNAL OF MOLDOVA 2009. [DOI: 10.19261/cjm.2009.04(2).06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Substituted indolizines are very attractive heterocyclic units. On developing efficient methods toward differently substituted indolizines, we were particularly interested in elaborating efficient approaches toward three-component reaction of these compounds which are very interested from the point of view fluorescent properties. The microwave-mediated three component reaction of acyl bromide, bipyridine and dipolarophyl is catalyzed by basic alumina to give corresponding bis-indolizines in excellent yields in a one –pot reaction.
Collapse
|